|
|
Characteristics of pulmonary tuberculosis patients complicated by diabetes mellitus in Quzhou City |
ZHANG Yating1, HAO Xiaogang2, WANG Wei2, JIAO Shilin2, FANG Chunfu2, ZHANG Xing2
|
1. School of Public Health, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310000, China; 2. Quzhou Center for Disease Control and Prevention, Quzhou, Zhejiang 324000, China |
|
|
Abstract Objective To analyze the epidemiological and clinical characteristics of pulmonary tuberculosis patients complicated by diabetes mellitus (PTB-DM), so as to provide insights into PTB-DM control. Methods The data pertaining to PTB cases in Quzhou City from 2016 to 2020 were extracted from Tuberculosis Information Management System of Chinese Disease Prevention and Control Information System. The demographic features, diagnosis and treatment of PTB-DM patients were descriptively analyzed, and compared with PTB patients. Results The incidence of PTB-DM was 6.79/105 to 9.27/105 in Quzhou City from 2016 to 2020, with an annual increase rate of 8.09%. Among all PTB-DM patients, there were 674 men (76.94%), 620 cases at ages of 60 years and older (70.78%), 564 cases living in urban areas (64.38%), 619 farmers (70.66%), 537 cases with delay in healthcare-seeking (61.30%), 802 treatment-naïve cases (91.55%), 547 cases positive for pathogenic tests (62.44%), 11 cases with rifampicin resistance (1.26%), 695 cases with negative conversion of sputum smears 2 months post-treatment (79.34%), and 783 cases with successful treatment (89.38%). The proportions of men, ages of 60 years and older, living in urban areas, farmers, delay in healthcare-seeking, positive pathogenic tests and rifampicin resistance were significantly higher among PTB-DM patients than among PTB patients, and the negative conversion rate of sputum smears 2 months post-treatment was significantly lower among PTB-DM patients than among PTB patients (all P<0.05). Conclusions The incidence of PTB-DM increased year by year in Quzhou City from 2016 to 2020, and PTB-DM cases were predominantly found among elderly men. The proportion of delay in healthcare-seeking, positive pathogenic tests and rifampicin resistance was higher among PTB-DM patients than among PTB patients.
|
Received: 22 September 2022
Revised: 24 October 2022
Published: 11 January 2023
|
|
|
|
|
[1] World Health Organization.Global Tuberculosis Report 2021[R].Geneva:World Health Organization,2021. [2] SUN H,SAEEDI P,KARURANGA S,et al.IDF diabetes atlas:global,regional and country-level diabetes prevalence estimates for 2021 and projections for 2045[J/OL].Diabetes Res Clin Pract,2022,183(2022-01-01)[2022-10-24].http://doi.org/110.1016/j.diabres.2021.109119. [3] AL-RIFAI R H,PEARSON F,CRITCHLEY J A,et al.Association between diabetes mellitus and active tuberculosis:a systematic review and meta-analysis[J/OL].PLoS One,2017,12(11)(2017-09-21)[2022-10-24].http://doi.org/10.1371/journal.pone.0187967. [4] 高见. HIV或2型糖尿病合并肺结核与单纯肺结核临床特征的研究[D].大连:大连医科大学,2017. [5] SINHA P,MOLL A P,BROOKS R P,et al.Synergism between diabetes and human immunodeficiency virus in increasing the risk of tuberculosis[J].Int J Tuberc Lung Dis,2018,22(7):793-799. [6] 中华人民共和国国家卫生和计划生育委员会.结核病分类:WS 196—2017[S].2018. [7] 中华人民共和国国家卫生和计划生育委员会.肺结核诊断:WS 288—2017[S].2018. [8] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2020年版)[J].中华糖尿病杂志,2021,13(4):315-409. [9] 姚琳,顾斌斌,王霞芳,等.苏州地区2011年—2017年间9 528例肺结核患者合并症的原因分析及其分布趋势[J].抗感染药学,2019,16(2):258-261. [10] 汪清雅,庞艳,李建琼,等.2014—2018年重庆市肺结核合并糖尿病病例特征分析[J].预防医学,2021,33(5):476-478,483. [11] PODELL B K,ACKART D F,OBREGON-HENAO A,et al.Increased severity of tuberculosis in Guinea pigs with type 2 diabetes:a model of diabetes-tuberculosis comorbidity[J].Am J Pathol,2014,184(4):1104-1118. [12] 张海清,李莉,吴云亮,等.2016—2020年徐州市肺结核合并糖尿病患者流行病学特征及转归分析[J].江苏预防医学,2021,32(5):597-598. [13] 王黎霞,成诗明,陈明亭,等.2010年全国第五次结核病流行病学抽样调查报告[J].中国防痨杂志,2012,34(8):485-508. [14] 李晓蓉,庞学文.社区糖尿病患者结核病筛查的可行性分析[J].华西医学,2021,36(10):1465-1468. [15] LÖNNROTH K,ROGLIC G,HARRIES A D.Improving tuberculosis prevention and care through addressing the global diabetes epidemic:from evidence to policy and practice[J].Lancet Diabetes Endocrinol,2014,2(9):730-739. [16] RESTREPO B I,SCHLESINGER L S.Impact of diabetes on the natural history of tuberculosis[J].Diabetes Res Clin Pract,2014,106(2):191-199. [17] LEE P,FU H,LAI T C,et al.Glycemic control and the risk of tuberculosis:a cohort study[J/OL].PLoS Med,2016,13(8)(2016-08-09)[2022-10-24].http://doi.org/10.1371/journal.pmed.1002072. |
|
|
|